High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy

High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy Soheila Rostami Department of Biology, Parand Branch, Islamic Azad University, Parand, Iran http://orcid.org/0000-0002-3421-335X Farzaneh Tafvizi Department of Biology, Parand Branch, Islamic Azad University, Parand, Iran http://orcid.org/0000-0002-3595-5021 Hamid Reza Kheiri Manjili Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

Introduction: Due to the side effects of drugs, the development of nanoscale drug delivery systems has led to a significant improvement in medicinal therapies due to drug pharmacokinetics changes, decreased toxicity, and increased half-life of the drug. This study aimed to synthesize tamoxifen (TMX)-loaded L-lysine coated magnetic iron oxide nanoparticles as a nano-carrier to investigate its cytotoxic effects and anti-cancer properties against MCF-7 cancer cells. Methods: Magnetic Fe3O4 nanoparticles were synthesized and coated with L-lysine (F-Lys NPs). Then, TMX was loaded onto these NPs. The characteristics of synthesized nanoparticles (F-Lys-TMX NPs) were evaluated by X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), differential scanning calorimetry (DSC), vibrating sample magnetometer (VSM), and thermogravimetric analysis (TGA). The drug release was analyzed at pH 5.8 and pH 7.4. The MCF-7 cells were exposed to F-Lys-TMX NPs, F-Lys NPs, and TMX for 24, 48, and 72 hours. To evaluate the cytotoxic potential of designed nanoparticles, MTT and apoptosis assays, real-time PCR, and cell cycle analysis was carried out. Results: The F-Lys-TMX NPs had spherical morphology with a size ranging from 9 to 30 nm. By increasing the nanoparticles concentration and treatment time, more cell proliferation inhibition and apoptosis induction were observed in F-Lys-TMX NPs-treated cells compared to the TMX. The expression levels of ERBB2, cyclin D1, and cyclin E genes were down-regulated and expression levels of the caspase-3 and caspase-9 genes were up-regulated. Studies on the drug release revealed a slow and controlled pH-dependent release of the nanoparticles. Cell cycle analysis indicated that F-Lys-TMX NPs could arrest the cells at the G0/G1 phase. Conclusion: The findings suggest that F-Lys-TMX NPs are more effective and have the potential for cell proliferation inhibition and apoptosis induction compared to the TMX. Hence, F-Lys-TMX NPs can be considered as an anti-cancer agent against MCF-7 breast cancer cells.
12 01 2021 07 01 2022 301 313 1 10.34172/crossmark_policy bi.tbzmed.ac.ir false Tabriz University of Medical Sciences Tabriz University of Medical Sciences 2020-08-11 2020-11-14 2021-12-01 10.34172/bi.2021.23337 20220801143713 https://bi.tbzmed.ac.ir/Article/bi-23337 https://bi.tbzmed.ac.ir/PDF/bi-12-301.pdf https://bi.tbzmed.ac.ir/PDF/bi-12-301.pdf https://bi.tbzmed.ac.ir/PDF/bi-12-301.pdf https://bi.tbzmed.ac.ir/PDF/bi-12-301.pdf https://bi.tbzmed.ac.ir/PDF/bi-12-301.pdf 10.1002/ijc.29210 10.30476/MEJC.2018.42130 10.4137/BCBCR.S23794 10.4184/asj.2016.10.4.787 10.1016/s0029-7844(00)01196-0 10.1002/(sici)1097-0339(199812)192??? doi.org/10.1038/nrd1984 10.1016/j.bbamcr.2003.08.009 10.1038/sj.onc.1206932 10.1016/j.tibs.2006.01.006 10.1016/j.jconrel.2005.03.006 10.1016/j.colsurfb.2013.01.051 10.1016/j.ctrv.2008.04.003 10.3390/ijms10020646 10.1016/s0167-4889(98)00002-0 10.1016/S0142-9612(01)00267-8 10.1093/jnci/90.18.1371 10.1088/2043-6254/aa5e33 10.1007/s11671-008-9174-9 10.1016/j.carbpol.2013.10.028 10.1016/j.biomaterials.2012.01.058 10.1016/j.ijcard.2011.06.004 10.1016/j.jenvman.2020.110831 10.1039/c1cs15248c 10.1002/cmmi.494 10.1021/ja049195r 10.1142/p432 Torchilin VP. Nanoparticulates as drug carriers: Imperial college press; 2006. 10.1021/bc900424u 10.1016/j.biomaterials.2004.10.012 10.1007/s00204-011-0773-3 10.1021/acs.jpcc.5b07195 10.1021/acs.jpcc.6b03180 10.5012/bkcs.2012.33.12.3957 ACS nano Massive intracellular biodegradation of iron oxide nanoparticles evidenced magnetically at single-endosome and tissue levels Mazuel F 10 7627 2016 10.1021/acsnano.6b02876 10.1016/j.colsurfa.2005.08.027 10.1007/s11051-006-9134-1 FEBS J Essential amino acid mixtures drive cancer cells to apoptosis through proteasome inhibition and autophagy activation Bonfili L 284 1726 2017 10.1111/febs.14081 10.1002/aoc.4069 10.1016/j.jallcom.2009.04.103 10.1016/j.jallcom.2010.06.022 Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath MIn vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080Med Oncol Roomi MW 23 105 2006 10.1016/j.addr.2012.04.010 10.1080/03639045.2017.1417422 10.1049/iet-nbt.2018.5069 10.1016/j.ijbiomac.2020.05.006 10.1039/b404964k 10.1080/10717540590968855 10.3109/10837450.2013.836218 10.3109/9781420016345-13 Chan CC. Selective estrogen receptor modulators. Gynecological Drug Therapy: CRC Press; 2016. p. 105-10. 10.3109/02652048.2011.651496 10.1002/jbm.a.32929 10.1126/science.7878463 10.1016/s0021-9290(02)00034-9 10.3109/17435390.2013.822115 10.1055/s-0043-106051 10.1055/s-0043-120197 10.1016/s0168-3659(01)00519-3 10.1016/s0168-3659(99)00248-5 10.1023/A:1011921324952 10.1016/j.jconrel.2013.03.018 10.2147/IJN.S27722 10.1007/s12274-012-0275-5 10.1021/nn300516g 10.1007/s13738-017-1286-7 10.1016/j.biomaterials.2006.07.014 j.colsurfb.2013.01.051 10.1007/978-3-642-32183-2_58 Akim AM, Tung EE, Chong PP, Hamzah MY, Dahlan KZM, editors. Nanoparticle-Encapsulated Tamoxifen Inducing Cytotoxic Effect on Mcf-7 Breast Cancer Cell Lines. Berlin, Heidelberg: Springer; 2013. j.biomaterials.2010.04.062 10.1155/2012/686108 10.1002/mabi.200400089 10.1016/j.breast.2006.02.005 10.1208/050203 10.1093/jnci/95.5.353 10.1038/nature07483 10.1016/j.ijpharm.2018.03.022 10.1080/17458080.2015.1038660